KR970002609B1 - 에리트로포이에틴 항빈혈작용 증강제 - Google Patents

에리트로포이에틴 항빈혈작용 증강제 Download PDF

Info

Publication number
KR970002609B1
KR970002609B1 KR1019930022562A KR930022562A KR970002609B1 KR 970002609 B1 KR970002609 B1 KR 970002609B1 KR 1019930022562 A KR1019930022562 A KR 1019930022562A KR 930022562 A KR930022562 A KR 930022562A KR 970002609 B1 KR970002609 B1 KR 970002609B1
Authority
KR
South Korea
Prior art keywords
spherical
group
rhuepo
anemia
coal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930022562A
Other languages
English (en)
Korean (ko)
Other versions
KR940008690A (ko
Inventor
미찌히또 이세
에이오 히야시
Original Assignee
구레하 가가꾸 고교 가부시끼가이샤
고다마 슌이찌로
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구레하 가가꾸 고교 가부시끼가이샤, 고다마 슌이찌로 filed Critical 구레하 가가꾸 고교 가부시끼가이샤
Publication of KR940008690A publication Critical patent/KR940008690A/ko
Application granted granted Critical
Publication of KR970002609B1 publication Critical patent/KR970002609B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019930022562A 1992-10-29 1993-10-28 에리트로포이에틴 항빈혈작용 증강제 Expired - Fee Related KR970002609B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31418192 1992-10-29
JP92-314181 1992-10-29

Publications (2)

Publication Number Publication Date
KR940008690A KR940008690A (ko) 1994-05-16
KR970002609B1 true KR970002609B1 (ko) 1997-03-06

Family

ID=18050237

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930022562A Expired - Fee Related KR970002609B1 (ko) 1992-10-29 1993-10-28 에리트로포이에틴 항빈혈작용 증강제

Country Status (8)

Country Link
US (1) US5399551A (enExample)
EP (1) EP0595716A1 (enExample)
KR (1) KR970002609B1 (enExample)
CN (1) CN1090175A (enExample)
AU (1) AU657439B2 (enExample)
CA (1) CA2108330C (enExample)
PH (1) PH30280A (enExample)
TW (1) TW270086B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US5951996A (en) * 1998-02-04 1999-09-14 Czeizler Zaharia; Veronica L. Treatment of chronic diffuse GI bleeding with erythropoietin
RU2128517C1 (ru) * 1998-07-20 1999-04-10 Колобков Сергей Леонидович Стабилизированный водный раствор эритропоэтина
US6703480B1 (en) * 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
US6956023B1 (en) 2001-04-19 2005-10-18 University Of Florida Materials and methods for providing nutrition to neonates
US6833351B2 (en) 2001-05-21 2004-12-21 Douglas T. Dieterich Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
KR101135260B1 (ko) * 2003-10-22 2012-04-12 가부시키가이샤 쿠레하 경구투여용 흡착제, 신질환 치료 또는 예방제 및 간질환치료 또는 예방제
US8247072B2 (en) 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
US20070191571A1 (en) * 2006-02-14 2007-08-16 Sink Chester W Resol beads, methods of making them, and methods of using them
US20070191572A1 (en) * 2006-02-14 2007-08-16 Tustin Gerald C Resol beads, methods of making them, and methods of using them
US20070207917A1 (en) * 2006-02-14 2007-09-06 Chester Wayne Sink Activated carbon monoliths and methods of making them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
JPS57189669A (en) * 1981-05-19 1982-11-22 Toushiyou Bussan Kk Spirillum composition
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0549694A (ja) * 1991-08-28 1993-03-02 Asahi Medical Co Ltd 造影剤の吸着体

Also Published As

Publication number Publication date
US5399551A (en) 1995-03-21
AU4915393A (en) 1994-05-12
CA2108330C (en) 1998-12-08
PH30280A (en) 1997-02-20
TW270086B (enExample) 1996-02-11
KR940008690A (ko) 1994-05-16
EP0595716A1 (en) 1994-05-04
CA2108330A1 (en) 1994-04-30
CN1090175A (zh) 1994-08-03
AU657439B2 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
KR970002609B1 (ko) 에리트로포이에틴 항빈혈작용 증강제
CA2150184C (en) Pharmaceutical composition for the treatment of inflammatory bowel diseases
KR970002613B1 (ko) 항네프로제증후군제
AU658338B2 (en) Antidiabetic agent
CA2162086A1 (en) Agent for reducing nephrotoxicity due to medicine
JPS60231617A (ja) 損傷消化管の治癒を促進する医薬組成物
EP0688566B1 (en) Use of spherical activated carbon for the treatment of hemorrhoidal diseases
JP3585514B2 (ja) エリスロポエチン抗貧血作用の増強剤
JPH10316578A (ja) リポタンパク質リパーゼ低血症改善剤
WO2010104056A1 (ja) 寿命延長剤
JP2799553B2 (ja) 抗痔疾患剤
WO2004089384A1 (ja) 低代謝回転骨症の治療又は予防剤
JP2011111414A (ja) 抗貧血剤
JPH10273443A (ja) 副甲状腺ホルモン軽減剤
KR100600635B1 (ko) 경구투여용 흡착제 및 상기 경구투여용 흡착제를 포함하는의약조성물
US20070231394A1 (en) Agent for Removing Circulatory Dysfunction Factor
WO2006033341A1 (ja) 糖尿病性神経障害治療又は予防剤
CA2438763A1 (en) Blood coagulation factor xiii for treating platelet disorders
HK1099634A (en) Agent for removing factor causing circulatory dysfunction

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

FPAY Annual fee payment

Payment date: 20000229

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20010712

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20010712

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000